Zach Jonasson PhD

Managing Partner, Phoenix Venture Partners (PVP)

Dr. Jonasson is a Managing Partner and co-founder of Phoenix Venture Partners (PVP) where he focuses on life sciences and healthcare related investments. He brings over 25 years of experience in venture capital, entrepreneurship, and start-ups operations. He was the co-founder and initial CEO of ReForm Biologics, a start-up developing next generation formulations technologies for biotherapeutics, and a cofounder of Crop Enhancement, a start-up developing sustainable pesticides and fertilizers for sustainable agriculture. Previously, he was a General Partner and Kauffman Fellow at Seaflower Ventures, where his prior investments included Serenex (acquired), MetaWorks (acquired), and Valeritas (VLRX). Earlier in his career, while still a doctoral student, Dr. Jonasson was part of the initial five person team at RCM (acquired), where he designed process optimization instrumentation for major chemicals and energy companies, including Eastman Chemical, Shell, and Sempra.

Dr. Jonasson earned a BS from Georgetown University and an AM and PhD from Harvard University, where he was a Sackler Scholar. He has taught at Harvard Business School. In addition to his investment and board roles at PVP, Dr. Jonasson serves on the board of the Oregon Translational Research and Development Institute (OTRADI), on the Commercialization Council of the Oregon Nanoscience and Microtechnologies Institute (ONAMI), on the Advisory Board for the Oregon Innovation Cluster (OIC), and on the Advisory Board of the Life Sciences Institute at the University of British Columbia. Dr. Jonasson is based in Seattle where he enjoys hiking and kayaking with his wife and two children.


Current Investments:

AbSci, Autonomic Materials, BroadSpotCrop Enhancement, Traycer Diagnostics Systems, ReForm BiologicsSentinel Monitoring Systems


 

Cross_3